HEADER HYDROLASE 26-MAY-06 2IU0 TITLE CRYSTAL STRUCTURES OF TRANSITION STATE ANALOGUE INHIBITORS OF INOSINE TITLE 2 MONOPHOSPHATE CYCLOHYDROLASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE, COMPND 5 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE, COMPND 6 AICAR TRANSFORMYLASE, IMP CYCLOHYDROLASE, ATIC, IMP SYNTHASE, COMPND 7 INOSINICASE; COMPND 8 EC: 2.1.2.3, 3.5.4.10; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: BIFUNCTIONAL ENZYME SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS MULTIFUNCTIONAL ENZYME, TRANSITION STATE ANALOGUE, ATIC, IMPCH, KEYWDS 2 HYDROLASE, INHIBITOR, TRANSFERASE, STRUCTURE-BASE, PURINE KEYWDS 3 BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR L.XU,Y.CHONG,I.HWANG,A.D.ONOFRIO,K.AMORE,G.P.BEARDSLEY,C.LI, AUTHOR 2 A.J.OLSON,D.L.BOGER,I.A.WILSON REVDAT 5 22-MAY-19 2IU0 1 REMARK REVDAT 4 13-MAR-13 2IU0 1 COMPND SOURCE KEYWDS SPRSDE REVDAT 4 2 1 JRNL REMARK VERSN FORMUL REVDAT 4 3 1 MASTER REVDAT 3 24-FEB-09 2IU0 1 VERSN REVDAT 2 15-MAY-07 2IU0 1 JRNL REVDAT 1 20-FEB-07 2IU0 0 SPRSDE 13-MAR-13 2IU0 2B0W JRNL AUTH L.XU,Y.CHONG,I.HWANG,A.D'ONOFRIO,K.AMORE,G.P.BEARDSLEY,C.LI, JRNL AUTH 2 A.J.OLSON,D.L.BOGER,I.A.WILSON JRNL TITL STRUCTURE-BASED DESIGN, SYNTHESIS, EVALUATION, AND CRYSTAL JRNL TITL 2 STRUCTURES OF TRANSITION STATE ANALOGUE INHIBITORS OF JRNL TITL 3 INOSINE MONOPHOSPHATE CYCLOHYDROLASE JRNL REF J.BIOL.CHEM. V. 282 13033 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17324932 JRNL DOI 10.1074/JBC.M607293200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.XU,C.LI,A.J.OLSON,I.A.WILSON REMARK 1 TITL CRYSTAL STRUCTURE OF AVIAN AICAR TRANSFORMYLASE IN COMPLEX REMARK 1 TITL 2 WITH A NOVEL NON-FOLATE INHIBITOR IDENTIFIED BY VIRTUAL REMARK 1 TITL 3 LIGAND SCREENING REMARK 1 REF J.BIOL.CHEM. V. 279 50555 2004 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 15355974 REMARK 1 DOI 10.1074/JBC.M406801200 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.LI,L.XU,A.J.OLSON,I.A.WILSON REMARK 1 TITL SUCCESSFUL VIRTUAL SCREENING FOR HUMAN AICAR TRANSFORMYLASE REMARK 1 TITL 2 INHIBITORS AGAINST NCI DIVERSITY SET USING AUTODOCK REMARK 1 REF J.MED.CHEM. V. 47 6681 2004 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 15615517 REMARK 1 DOI 10.1021/JM049504O REMARK 1 REFERENCE 3 REMARK 1 AUTH S.E.GREASLEY,P.HORTON,J.RAMCHARAN,G.P.BEARDSLEY, REMARK 1 AUTH 2 S.J.BENKOVIC,I.A.WILSON REMARK 1 TITL CRYSTAL STRUCTURE OF A BIFUNCTIONAL TRANSFORMYLASE AND REMARK 1 TITL 2 CYCLOHYDROLASE ENZYME IN PURINE BIOSYNTHESIS REMARK 1 REF NAT.STRUCT.BIOL. V. 8 402 2001 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 11323713 REMARK 1 DOI 10.1038/87555 REMARK 1 REFERENCE 4 REMARK 1 AUTH D.W.WOLAN,S.E.GREASLEY,G.P.BEARDSLEY,I.A.WILSON REMARK 1 TITL STRUCTURAL INSIGHTS INTO THE AVIAN AICAR TRANSFORMYLASE REMARK 1 TITL 2 MECHANISM REMARK 1 REF BIOCHEMISTRY V. 41 15505 2002 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12501179 REMARK 1 DOI 10.1021/BI020505X REMARK 1 REFERENCE 5 REMARK 1 AUTH D.W.WOLAN,S.E.GREASLEY,M.J.WALL,S.J.BENKOVIC,I.A.WILSON REMARK 1 TITL STRUCTURE OF AVIAN AICAR TRANSFORMYLASE WITH A REMARK 1 TITL 2 MULTISUBSTRATE ADDUCT INHIBITOR BETA-DADF IDENTIFIES THE REMARK 1 TITL 3 FOLATE BINDING SITE REMARK 1 REF BIOCHEMISTRY V. 42 10904 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12974624 REMARK 1 DOI 10.1021/BI030106H REMARK 1 REFERENCE 6 REMARK 1 AUTH D.W.WOLAN,C.G.CHEONG,S.E.GREASLEY,I.A.WILSON REMARK 1 TITL STRUCTURAL INSIGHTS INTO THE HUMAN AND AVIAN IMP REMARK 1 TITL 2 CYCLOHYDROLASE MECHANISM VIA CRYSTAL STRUCTURES WITH THE REMARK 1 TITL 3 BOUND XMP INHIBITOR REMARK 1 REF BIOCHEMISTRY V. 43 1171 2004 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 14756553 REMARK 1 DOI 10.1021/BI030162I REMARK 1 REFERENCE 7 REMARK 1 AUTH C.G.CHEONG,D.W.WOLAN,S.E.GREASLEY,P.A.HORTON,G.P.BEARDSLEY, REMARK 1 AUTH 2 I.A.WILSON REMARK 1 TITL CRYSTAL STRUCTURES OF HUMAN BIFUNCTIONAL ENZYME REMARK 1 TITL 2 AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE REMARK 1 TITL 3 TRANSFORMYLASE-IMP CYCLOHYDROLASE IN COMPLEX WITH POTENT REMARK 1 TITL 4 SULFONYL-CONTAINING ANTIFOLATES REMARK 1 REF J.BIOL.CHEM. V. 279 18034 2004 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 14966129 REMARK 1 DOI 10.1074/JBC.M313691200 REMARK 2 REMARK 2 RESOLUTION. 2.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 396365.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 41870 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1656 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6070 REMARK 3 BIN R VALUE (WORKING SET) : 0.3300 REMARK 3 BIN FREE R VALUE : 0.3800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 237 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9022 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.41000 REMARK 3 B22 (A**2) : 8.04000 REMARK 3 B33 (A**2) : 3.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.04000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.45 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.038 REMARK 3 BOND ANGLES (DEGREES) : 3.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 10.21 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 32.57 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : YC103.PAR REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : YC103.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2IU0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1290028908. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 93.0 REMARK 200 PH : 7.20 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE- ROOT REMARK 200 -BEAM SINGLE CRYSTAL REMARK 200 OPTICS : FLAT MIRROR, SINGLE CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 143040 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.530 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.61000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1G8M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%PEG3350, 0.2 M POTASSIUM NITRATE, REMARK 280 PH 7.20 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 193.50000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 193.50000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 53210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -90.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ALA B 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 114 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 18 -76.23 -39.46 REMARK 500 VAL A 19 -70.30 -32.12 REMARK 500 ARG A 23 -78.14 -53.85 REMARK 500 LEU A 30 119.82 -31.61 REMARK 500 ALA A 34 -177.83 -176.35 REMARK 500 SER A 35 -153.92 -151.69 REMARK 500 THR A 40 71.87 -67.42 REMARK 500 ALA A 41 -9.33 174.36 REMARK 500 ASP A 44 7.02 -66.78 REMARK 500 GLU A 60 151.19 -33.10 REMARK 500 LEU A 62 25.10 46.69 REMARK 500 VAL A 66 1.60 49.09 REMARK 500 ALA A 79 123.64 -32.83 REMARK 500 PRO A 106 116.75 -38.65 REMARK 500 PRO A 114 -81.02 -37.12 REMARK 500 VAL A 116 127.55 -26.07 REMARK 500 ASN A 139 43.84 -86.24 REMARK 500 ARG A 142 -52.89 -129.90 REMARK 500 TYR A 152 -59.39 -29.03 REMARK 500 SER A 153 -77.43 -51.38 REMARK 500 LYS A 267 113.39 -161.98 REMARK 500 LEU A 411 80.27 -163.40 REMARK 500 ASP A 503 -119.30 34.03 REMARK 500 GLN A 519 -178.71 -64.71 REMARK 500 ASP B 44 35.05 -77.06 REMARK 500 ASP B 54 27.86 -79.25 REMARK 500 LEU B 55 -32.51 -146.14 REMARK 500 GLU B 60 54.17 -68.00 REMARK 500 LEU B 62 17.10 55.21 REMARK 500 VAL B 66 -0.80 79.56 REMARK 500 PRO B 114 -75.74 -7.68 REMARK 500 VAL B 116 132.82 -34.25 REMARK 500 ASN B 139 43.19 -92.43 REMARK 500 ARG B 142 -43.54 -134.14 REMARK 500 TYR B 152 -61.17 -26.61 REMARK 500 SER B 153 -74.49 -52.33 REMARK 500 LYS B 163 39.34 -83.51 REMARK 500 ASP B 164 15.98 -170.54 REMARK 500 VAL B 202 -67.81 -107.49 REMARK 500 ASP B 292 1.15 -65.27 REMARK 500 THR B 296 22.60 -147.72 REMARK 500 SER B 314 1.34 -64.90 REMARK 500 ALA B 394 106.67 -53.33 REMARK 500 PHE B 401 32.84 -97.00 REMARK 500 ASP B 503 -123.68 66.79 REMARK 500 GLN B 510 -16.23 -49.53 REMARK 500 ALA B 567 18.08 -67.20 REMARK 500 ALA B 568 38.34 -161.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 304 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K A1594 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 429 O REMARK 620 2 VAL A 426 O 80.4 REMARK 620 3 SER A 431 OG 94.2 172.8 REMARK 620 4 SER A 433 OG 97.8 84.5 101.0 REMARK 620 5 ASP A 540 OD2 136.0 133.7 53.4 65.9 REMARK 620 6 HIS A 592 N 82.2 126.8 47.1 147.7 91.6 REMARK 620 7 LEU A 590 O 126.0 91.0 88.4 134.5 86.3 61.1 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 K B1594 K REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 540 OD2 REMARK 620 2 LEU B 590 O 86.3 REMARK 620 3 VAL B 426 O 132.5 91.6 REMARK 620 4 SER B 433 OG 65.7 144.4 91.9 REMARK 620 5 HIS B 592 N 91.7 59.7 127.3 137.9 REMARK 620 6 THR B 429 O 136.1 125.2 81.4 90.4 82.2 REMARK 620 7 SER B 431 OG 50.3 87.9 177.1 90.1 50.2 96.6 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K A 1594 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 1594 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 203 B 1595 DBREF 2IU0 A 1 593 UNP P31335 PUR9_CHICK 1 593 DBREF 2IU0 B 1 593 UNP P31335 PUR9_CHICK 1 593 SEQRES 1 A 593 MET ALA ALA ARG GLN GLN LEU ALA LEU LEU SER VAL SER SEQRES 2 A 593 GLU LYS ALA GLY LEU VAL GLU PHE ALA ARG SER LEU ASN SEQRES 3 A 593 ALA LEU GLY LEU GLY LEU ILE ALA SER GLY GLY THR ALA SEQRES 4 A 593 THR ALA LEU ARG ASP ALA GLY LEU PRO VAL ARG ASP VAL SEQRES 5 A 593 SER ASP LEU THR GLY PHE PRO GLU MET LEU GLY GLY ARG SEQRES 6 A 593 VAL LYS THR LEU HIS PRO ALA VAL HIS ALA GLY ILE LEU SEQRES 7 A 593 ALA ARG ASN ILE PRO GLU ASP ASN ALA ASP MET ASN LYS SEQRES 8 A 593 GLN ASP PHE SER LEU VAL ARG VAL VAL VAL CYS ASN LEU SEQRES 9 A 593 TYR PRO PHE VAL LYS THR VAL SER SER PRO GLY VAL THR SEQRES 10 A 593 VAL PRO GLU ALA VAL GLU LYS ILE ASP ILE GLY GLY VAL SEQRES 11 A 593 ALA LEU LEU ARG ALA ALA ALA LYS ASN HIS ALA ARG VAL SEQRES 12 A 593 THR VAL VAL CYS ASP PRO ALA ASP TYR SER SER VAL ALA SEQRES 13 A 593 LYS GLU MET ALA ALA SER LYS ASP LYS ASP THR SER VAL SEQRES 14 A 593 GLU THR ARG ARG HIS LEU ALA LEU LYS ALA PHE THR HIS SEQRES 15 A 593 THR ALA GLN TYR ASP ALA ALA ILE SER ASP TYR PHE ARG SEQRES 16 A 593 LYS GLU TYR SER LYS GLY VAL SER GLN LEU PRO LEU ARG SEQRES 17 A 593 TYR GLY MET ASN PRO HIS GLN SER PRO ALA GLN LEU TYR SEQRES 18 A 593 THR THR ARG PRO LYS LEU PRO LEU THR VAL VAL ASN GLY SEQRES 19 A 593 SER PRO GLY PHE ILE ASN LEU CYS ASP ALA LEU ASN ALA SEQRES 20 A 593 TRP GLN LEU VAL LYS GLU LEU LYS GLN ALA LEU GLY ILE SEQRES 21 A 593 PRO ALA ALA ALA SER PHE LYS HIS VAL SER PRO ALA GLY SEQRES 22 A 593 ALA ALA VAL GLY ILE PRO LEU SER GLU GLU GLU ALA GLN SEQRES 23 A 593 VAL CYS MET VAL HIS ASP LEU HIS LYS THR LEU THR PRO SEQRES 24 A 593 LEU ALA SER ALA TYR ALA ARG SER ARG GLY ALA ASP ARG SEQRES 25 A 593 MET SER SER PHE GLY ASP PHE ILE ALA LEU SER ASP ILE SEQRES 26 A 593 CYS ASP VAL PRO THR ALA LYS ILE ILE SER ARG GLU VAL SEQRES 27 A 593 SER ASP GLY VAL VAL ALA PRO GLY TYR GLU GLU GLU ALA SEQRES 28 A 593 LEU LYS ILE LEU SER LYS LYS LYS ASN GLY GLY TYR CYS SEQRES 29 A 593 VAL LEU GLN MET ASP PRO ASN TYR GLU PRO ASP ASP ASN SEQRES 30 A 593 GLU ILE ARG THR LEU TYR GLY LEU GLN LEU MET GLN LYS SEQRES 31 A 593 ARG ASN ASN ALA VAL ILE ASP ARG SER LEU PHE LYS ASN SEQRES 32 A 593 ILE VAL THR LYS ASN LYS THR LEU PRO GLU SER ALA VAL SEQRES 33 A 593 ARG ASP LEU ILE VAL ALA SER ILE ALA VAL LYS TYR THR SEQRES 34 A 593 GLN SER ASN SER VAL CYS TYR ALA LYS ASP GLY GLN VAL SEQRES 35 A 593 ILE GLY ILE GLY ALA GLY GLN GLN SER ARG ILE HIS CYS SEQRES 36 A 593 THR ARG LEU ALA GLY ASP LYS ALA ASN SER TRP TRP LEU SEQRES 37 A 593 ARG HIS HIS PRO ARG VAL LEU SER MET LYS PHE LYS ALA SEQRES 38 A 593 GLY VAL LYS ARG ALA GLU VAL SER ASN ALA ILE ASP GLN SEQRES 39 A 593 TYR VAL THR GLY THR ILE GLY GLU ASP GLU ASP LEU VAL SEQRES 40 A 593 LYS TRP GLN ALA MET PHE GLU GLU VAL PRO ALA GLN LEU SEQRES 41 A 593 THR GLU ALA GLU LYS LYS GLN TRP ILE ALA LYS LEU THR SEQRES 42 A 593 ALA VAL SER LEU SER SER ASP ALA PHE PHE PRO PHE ARG SEQRES 43 A 593 ASP ASN VAL ASP ARG ALA LYS ARG ILE GLY VAL GLN PHE SEQRES 44 A 593 ILE VAL ALA PRO SER GLY SER ALA ALA ASP GLU VAL VAL SEQRES 45 A 593 ILE GLU ALA CYS ASN GLU LEU GLY ILE THR LEU ILE HIS SEQRES 46 A 593 THR ASN LEU ARG LEU PHE HIS HIS SEQRES 1 B 593 MET ALA ALA ARG GLN GLN LEU ALA LEU LEU SER VAL SER SEQRES 2 B 593 GLU LYS ALA GLY LEU VAL GLU PHE ALA ARG SER LEU ASN SEQRES 3 B 593 ALA LEU GLY LEU GLY LEU ILE ALA SER GLY GLY THR ALA SEQRES 4 B 593 THR ALA LEU ARG ASP ALA GLY LEU PRO VAL ARG ASP VAL SEQRES 5 B 593 SER ASP LEU THR GLY PHE PRO GLU MET LEU GLY GLY ARG SEQRES 6 B 593 VAL LYS THR LEU HIS PRO ALA VAL HIS ALA GLY ILE LEU SEQRES 7 B 593 ALA ARG ASN ILE PRO GLU ASP ASN ALA ASP MET ASN LYS SEQRES 8 B 593 GLN ASP PHE SER LEU VAL ARG VAL VAL VAL CYS ASN LEU SEQRES 9 B 593 TYR PRO PHE VAL LYS THR VAL SER SER PRO GLY VAL THR SEQRES 10 B 593 VAL PRO GLU ALA VAL GLU LYS ILE ASP ILE GLY GLY VAL SEQRES 11 B 593 ALA LEU LEU ARG ALA ALA ALA LYS ASN HIS ALA ARG VAL SEQRES 12 B 593 THR VAL VAL CYS ASP PRO ALA ASP TYR SER SER VAL ALA SEQRES 13 B 593 LYS GLU MET ALA ALA SER LYS ASP LYS ASP THR SER VAL SEQRES 14 B 593 GLU THR ARG ARG HIS LEU ALA LEU LYS ALA PHE THR HIS SEQRES 15 B 593 THR ALA GLN TYR ASP ALA ALA ILE SER ASP TYR PHE ARG SEQRES 16 B 593 LYS GLU TYR SER LYS GLY VAL SER GLN LEU PRO LEU ARG SEQRES 17 B 593 TYR GLY MET ASN PRO HIS GLN SER PRO ALA GLN LEU TYR SEQRES 18 B 593 THR THR ARG PRO LYS LEU PRO LEU THR VAL VAL ASN GLY SEQRES 19 B 593 SER PRO GLY PHE ILE ASN LEU CYS ASP ALA LEU ASN ALA SEQRES 20 B 593 TRP GLN LEU VAL LYS GLU LEU LYS GLN ALA LEU GLY ILE SEQRES 21 B 593 PRO ALA ALA ALA SER PHE LYS HIS VAL SER PRO ALA GLY SEQRES 22 B 593 ALA ALA VAL GLY ILE PRO LEU SER GLU GLU GLU ALA GLN SEQRES 23 B 593 VAL CYS MET VAL HIS ASP LEU HIS LYS THR LEU THR PRO SEQRES 24 B 593 LEU ALA SER ALA TYR ALA ARG SER ARG GLY ALA ASP ARG SEQRES 25 B 593 MET SER SER PHE GLY ASP PHE ILE ALA LEU SER ASP ILE SEQRES 26 B 593 CYS ASP VAL PRO THR ALA LYS ILE ILE SER ARG GLU VAL SEQRES 27 B 593 SER ASP GLY VAL VAL ALA PRO GLY TYR GLU GLU GLU ALA SEQRES 28 B 593 LEU LYS ILE LEU SER LYS LYS LYS ASN GLY GLY TYR CYS SEQRES 29 B 593 VAL LEU GLN MET ASP PRO ASN TYR GLU PRO ASP ASP ASN SEQRES 30 B 593 GLU ILE ARG THR LEU TYR GLY LEU GLN LEU MET GLN LYS SEQRES 31 B 593 ARG ASN ASN ALA VAL ILE ASP ARG SER LEU PHE LYS ASN SEQRES 32 B 593 ILE VAL THR LYS ASN LYS THR LEU PRO GLU SER ALA VAL SEQRES 33 B 593 ARG ASP LEU ILE VAL ALA SER ILE ALA VAL LYS TYR THR SEQRES 34 B 593 GLN SER ASN SER VAL CYS TYR ALA LYS ASP GLY GLN VAL SEQRES 35 B 593 ILE GLY ILE GLY ALA GLY GLN GLN SER ARG ILE HIS CYS SEQRES 36 B 593 THR ARG LEU ALA GLY ASP LYS ALA ASN SER TRP TRP LEU SEQRES 37 B 593 ARG HIS HIS PRO ARG VAL LEU SER MET LYS PHE LYS ALA SEQRES 38 B 593 GLY VAL LYS ARG ALA GLU VAL SER ASN ALA ILE ASP GLN SEQRES 39 B 593 TYR VAL THR GLY THR ILE GLY GLU ASP GLU ASP LEU VAL SEQRES 40 B 593 LYS TRP GLN ALA MET PHE GLU GLU VAL PRO ALA GLN LEU SEQRES 41 B 593 THR GLU ALA GLU LYS LYS GLN TRP ILE ALA LYS LEU THR SEQRES 42 B 593 ALA VAL SER LEU SER SER ASP ALA PHE PHE PRO PHE ARG SEQRES 43 B 593 ASP ASN VAL ASP ARG ALA LYS ARG ILE GLY VAL GLN PHE SEQRES 44 B 593 ILE VAL ALA PRO SER GLY SER ALA ALA ASP GLU VAL VAL SEQRES 45 B 593 ILE GLU ALA CYS ASN GLU LEU GLY ILE THR LEU ILE HIS SEQRES 46 B 593 THR ASN LEU ARG LEU PHE HIS HIS HET K A1594 1 HET K B1594 1 HET 203 B1595 12 HETNAM K POTASSIUM ION HETNAM 203 1,5-DIHYDROIMIDAZO[4,5-C][1,2,6]THIADIAZIN-4(3H)-ONE 2, HETNAM 2 203 2-DIOXIDE FORMUL 3 K 2(K 1+) FORMUL 5 203 C4 H4 N4 O3 S FORMUL 6 HOH *253(H2 O) HELIX 1 1 GLY A 17 ALA A 27 1 11 HELIX 2 2 SER A 35 THR A 40 1 6 HELIX 3 3 LEU A 42 GLY A 46 5 5 HELIX 4 4 ASP A 51 GLY A 57 1 7 HELIX 5 5 HIS A 70 ALA A 79 1 10 HELIX 6 6 ILE A 82 ASP A 93 1 12 HELIX 7 7 PRO A 106 SER A 113 1 8 HELIX 8 8 THR A 117 GLU A 123 1 7 HELIX 9 9 ILE A 127 ASN A 139 1 13 HELIX 10 10 ASP A 151 SER A 162 1 12 HELIX 11 11 SER A 168 SER A 199 1 32 HELIX 12 12 GLY A 237 GLY A 259 1 23 HELIX 13 13 SER A 281 CYS A 288 1 8 HELIX 14 14 VAL A 290 LEU A 297 5 8 HELIX 15 15 THR A 298 ALA A 310 1 13 HELIX 16 16 ASP A 327 GLU A 337 1 11 HELIX 17 17 GLU A 348 LYS A 358 1 11 HELIX 18 18 LYS A 359 GLY A 362 5 4 HELIX 19 19 ASP A 397 LYS A 402 5 6 HELIX 20 20 PRO A 412 TYR A 428 1 17 HELIX 21 21 SER A 451 ARG A 469 1 19 HELIX 22 22 HIS A 471 SER A 476 1 6 HELIX 23 23 LYS A 484 THR A 497 1 14 HELIX 24 24 GLU A 502 ALA A 511 1 10 HELIX 25 25 THR A 521 ALA A 530 1 10 HELIX 26 26 ARG A 546 ILE A 555 1 10 HELIX 27 27 ALA A 568 LEU A 579 1 12 HELIX 28 28 GLY B 17 LEU B 28 1 12 HELIX 29 29 SER B 35 ASP B 44 1 10 HELIX 30 30 VAL B 52 GLY B 57 1 6 HELIX 31 31 GLU B 60 ARG B 65 5 6 HELIX 32 32 HIS B 70 ALA B 79 1 10 HELIX 33 33 ILE B 82 ASP B 93 1 12 HELIX 34 34 PRO B 106 VAL B 111 1 6 HELIX 35 35 THR B 117 ILE B 125 1 9 HELIX 36 36 ILE B 127 ASN B 139 1 13 HELIX 37 37 ASP B 151 SER B 162 1 12 HELIX 38 38 SER B 168 SER B 199 1 32 HELIX 39 39 GLY B 237 GLY B 259 1 23 HELIX 40 40 SER B 281 CYS B 288 1 8 HELIX 41 41 VAL B 290 LEU B 297 5 8 HELIX 42 42 THR B 298 GLY B 309 1 12 HELIX 43 43 ASP B 327 GLU B 337 1 11 HELIX 44 44 GLU B 348 GLY B 362 1 15 HELIX 45 45 ASP B 397 LYS B 402 5 6 HELIX 46 46 PRO B 412 TYR B 428 1 17 HELIX 47 47 SER B 451 ARG B 469 1 19 HELIX 48 48 HIS B 471 SER B 476 1 6 HELIX 49 49 LYS B 484 GLY B 498 1 15 HELIX 50 50 ASP B 503 ALA B 511 1 9 HELIX 51 51 THR B 521 ILE B 529 1 9 HELIX 52 52 ARG B 546 ARG B 554 1 9 HELIX 53 53 ALA B 568 LEU B 579 1 12 SHEET 1 AA 4 GLY A 31 ILE A 33 0 SHEET 2 AA 4 LEU A 7 SER A 11 1 O ALA A 8 N ILE A 33 SHEET 3 AA 4 VAL A 97 CYS A 102 1 N ARG A 98 O LEU A 7 SHEET 4 AA 4 THR A 144 VAL A 146 1 O THR A 144 N VAL A 100 SHEET 1 AB 4 GLN A 204 LEU A 207 0 SHEET 2 AB 4 ALA A 218 TYR A 221 -1 O ALA A 218 N LEU A 207 SHEET 3 AB 4 LEU B 385 LYS B 390 -1 O GLN B 386 N TYR A 221 SHEET 4 AB 4 ASN B 377 LEU B 382 -1 O GLU B 378 N GLN B 389 SHEET 1 AC 6 LEU A 229 ASN A 233 0 SHEET 2 AC 6 CYS A 364 MET A 368 -1 O VAL A 365 N VAL A 232 SHEET 3 AC 6 SER A 339 ALA A 344 1 O ASP A 340 N CYS A 364 SHEET 4 AC 6 ASP A 318 LEU A 322 1 O ASP A 318 N ASP A 340 SHEET 5 AC 6 ALA A 262 PHE A 266 -1 O ALA A 264 N ALA A 321 SHEET 6 AC 6 PRO A 271 VAL A 276 -1 N ALA A 272 O SER A 265 SHEET 1 AD 4 ASN A 377 LEU A 382 0 SHEET 2 AD 4 LEU A 385 LYS A 390 -1 O LEU A 385 N LEU A 382 SHEET 3 AD 4 ALA B 218 TYR B 221 -1 O GLN B 219 N MET A 388 SHEET 4 AD 4 GLN B 204 LEU B 207 -1 O LEU B 205 N LEU B 220 SHEET 1 AE 5 GLN A 441 GLY A 446 0 SHEET 2 AE 5 VAL A 434 LYS A 438 -1 O VAL A 434 N GLY A 446 SHEET 3 AE 5 VAL A 535 SER A 539 -1 O SER A 536 N ALA A 437 SHEET 4 AE 5 VAL A 557 PRO A 563 1 N GLN A 558 O VAL A 535 SHEET 5 AE 5 THR A 582 THR A 586 1 O THR A 582 N ILE A 560 SHEET 1 BA 5 VAL B 49 ASP B 51 0 SHEET 2 BA 5 GLY B 31 ALA B 34 1 O LEU B 32 N ARG B 50 SHEET 3 BA 5 LEU B 7 VAL B 12 1 O ALA B 8 N ILE B 33 SHEET 4 BA 5 VAL B 97 ASN B 103 1 N ARG B 98 O LEU B 7 SHEET 5 BA 5 THR B 144 VAL B 146 1 O THR B 144 N VAL B 100 SHEET 1 BB 6 LEU B 229 ASN B 233 0 SHEET 2 BB 6 CYS B 364 MET B 368 -1 O VAL B 365 N VAL B 232 SHEET 3 BB 6 SER B 339 ALA B 344 1 O ASP B 340 N CYS B 364 SHEET 4 BB 6 ASP B 318 LEU B 322 1 O ASP B 318 N ASP B 340 SHEET 5 BB 6 ALA B 262 PHE B 266 -1 O ALA B 264 N ALA B 321 SHEET 6 BB 6 PRO B 271 VAL B 276 -1 N ALA B 272 O SER B 265 SHEET 1 BC 5 GLN B 441 GLY B 446 0 SHEET 2 BC 5 VAL B 434 LYS B 438 -1 O VAL B 434 N GLY B 446 SHEET 3 BC 5 VAL B 535 SER B 539 -1 O SER B 536 N ALA B 437 SHEET 4 BC 5 VAL B 557 PRO B 563 1 N GLN B 558 O VAL B 535 SHEET 5 BC 5 THR B 582 THR B 586 1 O THR B 582 N ILE B 560 LINK K K A1594 O THR A 429 1555 1555 3.06 LINK K K A1594 O VAL A 426 1555 1555 2.87 LINK K K A1594 OG SER A 431 1555 1555 3.12 LINK K K A1594 OG SER A 433 1555 1555 2.98 LINK K K A1594 OD2 ASP A 540 1555 1555 3.27 LINK K K A1594 N HIS A 592 1555 1555 3.66 LINK K K A1594 O LEU A 590 1555 1555 2.91 LINK K K B1594 OD2 ASP B 540 1555 1555 3.17 LINK K K B1594 O LEU B 590 1555 1555 2.91 LINK K K B1594 O VAL B 426 1555 1555 2.78 LINK K K B1594 OG SER B 433 1555 1555 2.93 LINK K K B1594 N HIS B 592 1555 1555 3.71 LINK K K B1594 O THR B 429 1555 1555 3.01 LINK K K B1594 OG SER B 431 1555 1555 3.05 CISPEP 1 SER A 216 PRO A 217 0 -0.39 CISPEP 2 SER A 431 ASN A 432 0 -1.62 CISPEP 3 SER B 216 PRO B 217 0 -0.36 CISPEP 4 SER B 431 ASN B 432 0 -1.07 SITE 1 AC1 7 VAL A 426 THR A 429 SER A 431 SER A 433 SITE 2 AC1 7 ASP A 540 LEU A 590 HIS A 592 SITE 1 AC2 7 VAL B 426 THR B 429 SER B 431 SER B 433 SITE 2 AC2 7 ASP B 540 LEU B 590 HIS B 592 SITE 1 AC3 6 SER B 11 LYS B 15 GLY B 36 GLY B 37 SITE 2 AC3 6 THR B 38 LYS B 67 CRYST1 387.000 57.000 62.100 90.00 98.90 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.002584 0.000000 0.000405 0.00000 SCALE2 0.000000 0.017544 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016299 0.00000 MTRIX1 1 0.802300 -0.178100 0.569700 39.10000 1 MTRIX2 1 -0.188200 -0.981200 0.041600 25.10000 1 MTRIX3 1 -0.566400 0.073900 -0.820800 116.00000 1 MASTER 434 0 3 53 39 0 6 9 0 0 0 92 END